Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status FTI Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher Similarweb Q1 2026 Earnings EPS Slightly Below Estimates but Shares Rally on Strategic Momentum JKS Q4 2025 Earnings Loss per Share Misses Estimates by a Wide Margin Yet Stock Edges Higher SCSC Q1 2026 Earnings EPS Slightly Misses Estimates Sentiment Remains Cautiously Optimistic KALA Q4 2025 Earnings Loss Narrows Sharply on Disciplined Cost Management